April 18, 2013 / 11:39 AM / 4 years ago

MARKET PULSE- Pepsi, Select Comfort, Nokia, American Express

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s)

April 18 (Reuters) - Some U.S. stocks to watch on Thursday:

FUTURES SIGNAL HIGHER OPEN

Index futures pointed to a slightly higher open on Wall Street. Futures for the S&P 500, the Dow Jones and the Nasdaq 100 were up 0.1 to 0.2 percent.

** PEPSICO INC, Wednesday close $78.85, up 1 pct premarket

The maker of Pepsi sodas, Tropicana juices, Frito-Lay snacks and Quaker oatmeal reported better-than-expected first-quarter earnings, as price increases helped margins.

** NOKIA , Wednesday close $3.58, down 13 pct premarket

A big fall in sales of the company’s basic phones overshadowed a stronger performance from its Lumia smartphones in the first quarter, and it said it expected operating margins to deteriorate.

Chief Executive Stephen Elop said tougher competition was the main reason behind the fall in sales of regular mobile phones.

** AMERICAN EXPRESS CO, Wednesday close $64.13, down 1.5 pct after market

The credit card company’s first-quarter revenue came in below analysts’ expectations as cardmember spending growth remained muted.

** UNITEDHEALTH GROUP INC, Wednesday close $62.03

The nation’s largest health insurer said its first-quarter profit had fallen, in part because of lower government payments for its private Medicare services and prescription plans for older Americans.

** SELECT COMFORT CORP, Wednesday close $17.56, down 15 pct after market

The specialty mattress maker said it would revert to its earlier marketing strategy after a shift in advertising reduced exposure of its products to already cautious customers and hit sales.

** ALLISON TRANSMISSION HOLDINGS INC, Wednesday close $21.16, up 9 pct after market

The maker of fully-automatic transmissions said late on Wednesday that investment funds affiliated with Carlyle Group LP and Onex Corp would not proceed with a secondary offering of Allison Transmission’s common stock due to market conditions.

** SANDISK CORP, Wednesday close $55.72, up 3 pct premarket

The company raised its forecast for revenue this year and said it expects higher prices for its NAND memory chips, which are used in smartphones and tablets.

** EBAY INC, Wednesday close $56.10, down 3.6 pct premarket

The e-commerce company gave a disappointing earnings forecast for the second quarter and said Europe was weak, pushing its shares lower in after-hours trade.

** ROPER INDUSTRIES INC, Wednesday close $120.54,

The diversified U.S. manufacturer said it would buy healthcare services company Managed Health Care Associates Inc for $1 billion in an all-cash deal to expand its presence in the healthcare market.

** THERAVANCE INC, Wednesday close $28.01, up 18 pct after market

An advisory panel to the U.S. Food and Drug Administration has recommended that the agency approve an experimental treatment for smoking-related lung damage made by Britain’s GlaxoSmithKline Plc and Theravance.

** VALE SA ADR >, Wednesday close $15.82, up 2.5 pct after market

The top global iron ore miner’s mega ship called at a port in eastern China this week, marking the first entry of the vessels since Beijing banned them in January 2012.

** KEYCORP, Friday close $9.53

The bank reported first-quarter results which marginally beat estimates helped by lower expenses and commercial loan growth.

** ACCURAY INCORPORATED, Wednesday close $4.44

The radiation oncology company said it started on March 19 voluntary recalls of two separate components from its radiotheraphy product line CyberKnife. “The affected parts are manufactured by third-party suppliers and are being removed from the system because they failed to meet the company’s specifications and standards for quality,” Accuray said in a statement.

** SINOVAC BIOTECH LTD, Wednesday close $4.13, up 2 pct premarket

The pharmaceutical company said the Mexico health regulator granted marketing approval to its seasonal flu vaccine, named Anflu. Sinovac said the certificate of commercial approval is valid from April 1, 2013 to April 1, 2018. (Compiled by Aditi Shrivastava; Editing by Joyjeet Das)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below